Patient Guide: A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 66 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07728188
Status: UPCOMING
Condition: Relapsed or Refractory Multiple Myeloma
Phase: Phase III

Find a Study Location Near You

This study is available at 66 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Cerritos, California
  • Los Angeles, California
  • • And 63 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily